The Use of Single-Domain Antibodies from Camelidae for the Inhibition of Clostridium difficile Toxins A and B

被引：0
|
作者：
Wall, Susan
Akman, Alexandra
Chafe, Zachary
Chow, Alyssa
Deng, Mirella
Dumitrascu, Flavia
Erisoglu-Akyildiz, Kayra
Hernandez-Oviedo, Isabela
Hu, Kevin
Muscant, Rebecca
Tanya Nguyen
Niu, Catherina
Rulko, Theo
Samad, Hana
Sullivan, Nicholas
Wa, Ewan
Wu, Yuxin
Xiao, Mason
机构：
来源：
FASEB JOURNAL | 2018年 / 32卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
lb202
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
    Andersen, Kasper Krogh
    Strokappe, Nika M.
    Hultberg, Anna
    Truusalu, Kai
    Smidt, Imbi
    Mikelsaar, Raik-Hiio
    Mikelsaar, Marika
    Verrips, Theo
    Hammarstrom, Lennart
    Marcotte, Harold
    INFECTION AND IMMUNITY, 2016, 84 (02) : 395 - 406
  • [2] Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain
    Hussack, Greg
    Arbabi-Ghahroudi, Mehdi
    van Faassen, Henk
    Songer, J. Glenn
    Ng, Kenneth K. -S.
    MacKenzie, Roger
    Tanha, Jamshid
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (11) : 8961 - 8976
  • [3] Fit-for-purpose heterodivalent single-domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile
    Rodriguez, Everardo R. Rodriguez
    Nordvang, Rune Thorbjorn
    Petersson, Marcus
    Rendsvig, Jakob Kraemmer Haar
    Arendrup, Emma Wenzel
    Quintero, Monica L. Fernandez
    Jenkins, Timothy P.
    Laustsen, Andreas H.
    Thrane, Sandra Wingaard
    PROTEIN SCIENCE, 2024, 33 (07)
  • [4] β-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae
    Conrath, KE
    Lauwereys, M
    Galleni, M
    Matagne, A
    Frère, JM
    Kinne, J
    Wyns, L
    Muyldermans, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2807 - 2812
  • [5] Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
    Lowy, Israel
    Molrine, Deborah C.
    Leav, Brett A.
    Blair, Barbra M.
    Baxter, Roger
    Gerding, Dale N.
    Nichol, Geoffrey
    Thomas, William D., Jr.
    Leney, Mark
    Sloan, Susan
    Hay, Catherine A.
    Ambrosino, Donna M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (03): : 197 - 205
  • [6] ANYL 120-Llama-derived single-domain antibodies for targeting toxins
    Swain, Marla D.
    Goldman, Ellen R.
    Anderson, George P.
    Liu, Jinny
    Bernstein, Rachael D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [7] Properties and action of toxins A and B of Clostridium difficile
    Cygan, Z
    Cygan, W
    MEDYCYNA WETERYNARYJNA, 2000, 56 (01) : 15 - 17
  • [8] In Vitro and In Vivo Characterization of Neutralizing Monoclonal Antibodies Against Clostridium difficile Toxins a and B
    Staelens, Dominiek
    de Wouwer, Marlies Van
    Brouwers, Els
    Caluwaerts, Silvia
    Lacy, Borden
    Rottiers, Pieter
    Vanhoenacker, Peter
    Geukens, Nick
    Declerck, Paul J.
    Vermeire, Severine
    Rutgeerts, Paul J.
    Van Assche, Gert A.
    GASTROENTEROLOGY, 2013, 144 (05) : S185 - S185
  • [9] Antibodies to Clostridium difficile Toxins in Inflammatory Bowel Disease Patients
    Berg, Adam
    Qazi, Taha
    Wasan, Sharmeel
    Calderwood, Audrey
    Villafuerte-Galvez, Javier
    Kelly, Ciaran
    Farraye, Francis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S616 - S616
  • [10] Treatment with Monoclonal Antibodies against Clostridium difficile Toxins.
    Parks, Tom
    Gkrania-Klotsas, Effrossyni
    Nicholl, Claire
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1444 - 1444
12345